Literature DB >> 16049651

[Guidelines for therapy of chronic heart failure].

U C Hoppe1, M Böhm, R Dietz, P Hanrath, H K Kroemer, A Osterspey, A A Schmaltz, E Erdmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16049651     DOI： 10.1007/s00392-005-0268-4

Source DB:  PubMed          Journal:  Z Kardiol        ISSN： 0300-5860


× No keyword cloud information.
  92 in total

1.  A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.

Authors:  Eric J Eichhorn; Michael J Domanski; Heidi Krause-Steinrauf; Michael R Bristow; Philip W Lavori
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

Review 2.  Recommendations for exercise training in chronic heart failure patients.

Authors: 
Journal:  Eur Heart J       Date:  2001-01       Impact factor: 29.983

3.  The pathogenesis of acute pulmonary edema associated with hypertension.

Authors:  S K Gandhi; J C Powers; A M Nomeir; K Fowle; D W Kitzman; K M Rankin; W C Little
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

4.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Authors: 
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

5.  Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group.

Authors:  J N Cohn; S Ziesche; R Smith; I Anand; W B Dunkman; H Loeb; G Cintron; W Boden; L Baruch; P Rochin; L Loss
Journal:  Circulation       Date:  1997-08-05       Impact factor: 29.690

6.  Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

Authors:  Marcus D Flather; Marcelo C Shibata; Andrew J S Coats; Dirk J Van Veldhuisen; Aleksandr Parkhomenko; Joszef Borbola; Alain Cohen-Solal; Dan Dumitrascu; Roberto Ferrari; Philippe Lechat; Jordi Soler-Soler; Luigi Tavazzi; Lenka Spinarova; Jiri Toman; Michael Böhm; Stefan D Anker; Simon G Thompson; Philip A Poole-Wilson
Journal:  Eur Heart J       Date:  2005-01-09       Impact factor: 29.983

7.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

Authors:  Alan Kadish; Alan Dyer; James P Daubert; Rebecca Quigg; N A Mark Estes; Kelley P Anderson; Hugh Calkins; David Hoch; Jeffrey Goldberger; Alaa Shalaby; William E Sanders; Andi Schaechter; Joseph H Levine
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

8.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.

Authors:  J G F Cleland; K Swedberg; F Follath; M Komajda; A Cohen-Solal; J C Aguilar; R Dietz; A Gavazzi; R Hobbs; J Korewicki; H C Madeira; V S Moiseyev; I Preda; W H van Gilst; J Widimsky; N Freemantle; Joanne Eastaugh; J Mason
Journal:  Eur Heart J       Date:  2003-03       Impact factor: 29.983

9.  Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors.

Authors:  Aldo P Maggioni; Inder Anand; Sidney O Gottlieb; Roberto Latini; Gianni Tognoni; Jay N Cohn
Journal:  J Am Coll Cardiol       Date:  2002-10-16       Impact factor: 24.094

10.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Authors:  Marc A Pfeffer; John J V McMurray; Eric J Velazquez; Jean-Lucien Rouleau; Lars Køber; Aldo P Maggioni; Scott D Solomon; Karl Swedberg; Frans Van de Werf; Harvey White; Jeffrey D Leimberger; Marc Henis; Susan Edwards; Steven Zelenkofske; Mary Ann Sellers; Robert M Califf
Journal:  N Engl J Med       Date:  2003-11-10       Impact factor: 91.245
View more
  34 in total

Review 1.  [Treatment of progressive heart failure: pharmacotherapy, resynchronization (CRT), surgery].

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Herz       Date:  2010-03       Impact factor: 1.443

Review 2.  [Drug treatment of chronic heart failure].

Authors:  M Böhm; N Werner; M Kindermann
Journal:  Clin Res Cardiol       Date:  2006       Impact factor: 5.460

Review 3.  Management of end stage heart failure.

Authors:  Erik B Friedrich; Michael Böhm
Journal:  Heart       Date:  2007-05       Impact factor: 5.994

4.  Physicians' knowledge of and compliance with guidelines: an exploratory study in cardiovascular diseases.

Authors:  Ute Karbach; Ingrid Schubert; Jens Hagemeister; Nicole Ernstmann; Holger Pfaff; Hans-Wilhelm Höpp
Journal:  Dtsch Arztebl Int       Date:  2011-02-04       Impact factor: 5.594

Review 5.  [Heart failure update 2010 and current ESC guidelines].

Authors:  U C Hoppe; E Erdmann
Journal:  Herz       Date:  2010-12       Impact factor: 1.443

Review 6.  [Hypertension and cardiac failure].

Authors:  C M Schannwell; M G Hennersdorf; B E Strauer
Journal:  Internist (Berl)       Date:  2007-09       Impact factor: 0.743

7.  [Heart rate reduction as a therapeutic strategy: novel options].

Authors:  U C Hoppe
Journal:  Internist (Berl)       Date:  2006-12       Impact factor: 0.743

8.  Cost-effectiveness of cardiac resynchronization therapy in combination with an implantable cardioverter defibrillator (CRT-D) for the treatment of chronic heart failure from a German health care system perspective.

Authors:  Pamela Aidelsburger; Kristin Grabein; Volker Klauss; Jürgen Wasem
Journal:  Clin Res Cardiol       Date:  2007-10-25       Impact factor: 5.460

9.  Telemedical support in patients with chronic heart failure: experience from different projects in Germany.

Authors:  Axel Müller; Johannes Schweizer; Thomas M Helms; Micheal Oeff; Claudia Sprenger; Christian Zugck
Journal:  Int J Telemed Appl       Date:  2010-08-12

Review 10.  [Cardiac disease in patients with tumors and tumor therapy].

Authors:  U C Hoppe
Journal:  Internist (Berl)       Date:  2007-03       Impact factor: 0.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.